Literature DB >> 21520028

T lymphocyte activation in visceral adipose tissue of patients with oesophageal adenocarcinoma.

J Lysaght1, E H Allott, C L Donohoe, J M Howard, G P Pidgeon, J V Reynolds.   

Abstract

BACKGROUND: Visceral adipose tissue may fuel obesity-associated chronic inflammation and tumorigenesis. T cells may be important in visceral adipose tissue in driving inflammation, but they have not yet been characterized in patients with cancer. This study aimed to characterize T lymphocytes in visceral adipose tissue and peripheral blood from patients with oesophageal adenocarcinoma.
METHODS: Omental fat was taken from 35 patients with oesophageal adenocarcinoma at the start of surgery. Flow cytometry was performed to assess T cell activation status and cytokine production in omentum and peripheral blood.
RESULTS: A large population of lymphocytes was present in the omentum. Omental CD4(+) and CD8(+) T cells displayed significantly enhanced expression of the T cell activation markers CD69 (P < 0·001) and CD107a (CD8(+) T cells: P < 0·01), and significantly decreased CD62L expression (P < 0·05), compared with blood. Significantly higher proportions of CD45RO(+) T cells compared with CD45RA(+) T cells were present in omentum (P < 0·001 and P = 0·012 for CD4(+) and CD8(+) cells respectively). Interferon γ was the most abundant cytokine expressed by omental T cells, with a significantly higher level than in blood and subcutaneous adipose tissue (P < 0·01).
CONCLUSION: Visceral adipose tissue is a rich source of activated proinflammatory CD4(+) and CD8(+) T cells. It may fuel chronic inflammation via T cell-mediated pathways.
Copyright © 2011 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21520028     DOI: 10.1002/bjs.7498

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  14 in total

Review 1.  Adipose Tissue in HIV Infection.

Authors:  John R Koethe
Journal:  Compr Physiol       Date:  2017-09-12       Impact factor: 9.090

Review 2.  Signals from the Adipose Microenvironment and the Obesity-Cancer Link-A Systematic Review.

Authors:  Caroline Himbert; Mahmoud Delphan; Dominique Scherer; Laura W Bowers; Stephen Hursting; Cornelia M Ulrich
Journal:  Cancer Prev Res (Phila)       Date:  2017-09

3.  Parallel Profiles of Inflammatory and Effector Memory T Cells in Visceral Fat and Liver of Obesity-Associated Cancer Patients.

Authors:  Melissa J Conroy; Karen C Galvin; Suzanne L Doyle; Maria E Kavanagh; Ann-Marie Mongan; Aoife Cannon; Gillian Y Moore; John V Reynolds; Joanne Lysaght
Journal:  Inflammation       Date:  2016-10       Impact factor: 4.092

Review 4.  Could signal transducer and activator of transcription 3 be a therapeutic target in obesity-related gastrointestinal malignancy?

Authors:  Katie E O'Sullivan; John V Reynolds; Ciara O'Hanlon; Jacintha N O'Sullivan; Joanne Lysaght
Journal:  J Gastrointest Cancer       Date:  2014-03

5.  CCR1 antagonism attenuates T cell trafficking to omentum and liver in obesity-associated cancer.

Authors:  Melissa J Conroy; Karen C Galvin; Maria E Kavanagh; Ann Marie Mongan; Suzanne L Doyle; Niamh Gilmartin; Cliona O'Farrelly; John V Reynolds; Joanne Lysaght
Journal:  Immunol Cell Biol       Date:  2016-04-05       Impact factor: 5.126

6.  POU2AF1 promotes MSCs adipogenesis by inhibiting HDAC1 expression.

Authors:  Yaqing Wang; Luyang Wang; Zhongping Su; Wei Sun; Mi Zhang; Chuanxi Yang; Jingxin Zhou; Li Jiang; Xiangqing Kong
Journal:  Adipocyte       Date:  2021-12       Impact factor: 4.534

7.  Elevated Tumor Expression of PAI-1 and SNAI2 in Obese Esophageal Adenocarcinoma Patients and Impact on Prognosis.

Authors:  Emma H Allott; Melissa J Morine; Joanne Lysaght; Sarah A McGarrigle; Claire L Donohoe; John V Reynolds; Helen M Roche; Graham P Pidgeon
Journal:  Clin Transl Gastroenterol       Date:  2012-04-19       Impact factor: 4.488

Review 8.  Targeting T cell immunometabolism for cancer immunotherapy; understanding the impact of the tumor microenvironment.

Authors:  Mary B Mockler; Melissa J Conroy; Joanne Lysaght
Journal:  Front Oncol       Date:  2014-05-16       Impact factor: 6.244

Review 9.  Specialized immune responses in the peritoneal cavity and omentum.

Authors:  Mingyong Liu; Aaron Silva-Sanchez; Troy D Randall; Selene Meza-Perez
Journal:  J Leukoc Biol       Date:  2020-09-02       Impact factor: 4.962

10.  Infectious SIV resides in adipose tissue and induces metabolic defects in chronically infected rhesus macaques.

Authors:  Jacob Couturier; Neeti Agarwal; Pramod N Nehete; Wallace B Baze; Michael A Barry; K Jagannadha Sastry; Ashok Balasubramanyam; Dorothy E Lewis
Journal:  Retrovirology       Date:  2016-04-27       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.